Biome Australia
Biome Australia focuses on the licensing, development, and marketing of complementary medicines, including nutraceuticals and live biotherapeutics. The company operates within the household and personal products industry, aiming to provide innovative health solutions. Biome Australia distributes their products through pharmacies and health food stores.
Short position
Biome Australia (ASX:BIO) has 0.01% of its shares on issue reported as short positions as of 5 Oct 2026, or about 28,480 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.26% in January 2025. BIO is classified in the Household & Personal Products industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Biome Australia (BIO) company profile
Profile, insiders and operations
Company
AI-generated research profile of Biome Australia
BIO intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links